Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA).
- Disclosed ownership: 5.2%.
- Date of event: 28 Mar 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 5.2% ownership in Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA) on 28 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5.2% | 2,178,609 | 0 | 2,178,609 | /s/ Kevin Tang | Manager | |
| KEVIN TANG | 5.2% | 2,178,609 | 0 | 2,178,609 | /s/ Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 2.5% | 1,041,271 | 0 | 1,041,271 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 2.3% | 953,337 | 0 | 953,337 | /s/ Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0.3% | 139,379 | 0 | 139,379 | /s/ Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0.1% | 44,622 | 0 | 44,622 | /s/ Kevin Tang | Chief Executive Officer |